Grimm, Wesley A <br/><br/>
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.  [electronic resource] 

 -  Gut  Mar 2016 
 - 456-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2014-308735  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Autophagy-Related Proteins<br/>Biomarkers, Tumor--genetics<br/>Carrier Proteins--genetics<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Interferon Type I--metabolism<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Survival Analysis